65,437 trials
Gingival Inflammation · Plaque · Gingival Bleeding
Primary: Change From Baseline in Mean BPI Index Scores at 2 Weeks — 0.396; -1.028 score on a scale — p=0.022
Experiences With Health Care Coordination
Primary: Percent of Caregivers Who Reported That Their Child Has a Designated Care Coordinator — 864 Participants
Head and Neck Cancer
Primary: Complete Response Rate Achieved 1 Month After Concurrent Chemotherapy and Radiation Treatment — 52 Participants — p=< 0.01
HIV Infections
Primary: Percentage of Participants With Virologic Failure Endpoint as Per Food and Drug Administration (FDA) Snapshot Category at Week 48 — 0.3; 0.5 Percentage of participants
Delirium · Postoperative Complications
Primary: EEG During Delirium and After Recovery and in Patient Controls.
Arterial Disease
Primary: Evaluate SpO2 Accuracy Per Standards for Pulse Oximetry. — 3.1 percent
Pediatric Anesthesia · King Vision Video Laryngoscope Intubation
Primary: Ease of Endotracheal Intubation — 65 participants
Ulcer, Leg · Heal Wound
Primary: Number of Dressing Changes With Sensor Activation at Correct Timing — 0; 0; 4; 2 Dressing changes
Lymphoma
Primary: Response Rate R-HCVAD vs. R-CHOP — 40; 7; 2; 1 Participants
Patient Adherence · HIV Seronegativity
Primary: Adherence to PrEP — 85.6; 91.7; 81.6; 83.4 % participants with > 719 fmol/punch
Depressive Symptoms · Quality of Life
Primary: Change From Baseline in Mean Scores for Geriatric Depression Scale at 3 Weeks — 1.00; -.29 score on a scale — p=.113
Pressure Ulcer · Pressure Injury · Falls Injury
Primary: Usability Validation of Masimo Centroid System — 34 Participants
Diabetic Foot
Primary: Number of Participants Experiencing Clinical Failure — 26; 30 Participants
Diabetic Retinopathy · Macula Edema
Primary: Change in Central Retinal Thickness (CRT) — 384.62; 374; 349.15; 357.62 micrometer
Pancreatic Cancer · Colorectal Cancer · Non-Small Cell Lung Cancer
Primary: Participants With Dose Limiting Toxicities (DLT) — 0; 1; 3; 2 Participants